Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1378 (5 June), doi:10.1136/bmj.328.7452.1378-a
| The first 150 words of the full text of this article appear below. |
EDITORYamey says that only increased support from donor groups can save the Roll Back Malaria campaign.1 Three tools for malaria control are now offered for donors to support: nets, insecticides, and drugs. We should weigh our options before investing in each of these tools.
Malaria control programmes heavily based on insecticides are unsustainable by poor countries. Termination of external support for such programmes was followed by epidemics of malaria in communities that had lost their immunity during years of free insecticides.2
The bed net programmes in Africa have so far fallen far below expectations.1 With the spread of antimalarial drug resistance, provision of effective treatment is now assuming a more crucial role in determining the success or failure of malaria control.
Cheap firstline antimalarial drugs have now to be replaced by more expensive artemisinin based combination treatments. These are beyond the abilities of the national malaria programmes in
Ahmed A Abdel-Hameed Adeel, professor
Department of Pathology, College of Medicine, King Saud University, P O Box 2925, 11461 Riyadh, Saudi Arabia aadeel@ksu.edu.sa